↓ Skip to main content

Novel pharmacogenetic markers for treatment outcome in azathioprine‐treated inflammatory bowel disease

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, June 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel pharmacogenetic markers for treatment outcome in azathioprine‐treated inflammatory bowel disease
Published in
Alimentary Pharmacology & Therapeutics, June 2009
DOI 10.1111/j.1365-2036.2009.04057.x
Pubmed ID
Authors

M. A. SMITH, A. M. MARINAKI, M. ARENAS, M. SHOBOWALE‐BAKRE, C. M. LEWIS, A. ANSARI, J. DULEY, J. D. SANDERSON

Abstract

Azathioprine (AZA) pharmacogenetics are complex and much studied. Genetic polymorphism in TPMT is known to influence treatment outcome. Xanthine oxidase/dehydrogenase (XDH) and aldehyde oxidase (AO) compete with TPMT to inactivate AZA.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Netherlands 1 1%
Unknown 65 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 21%
Researcher 7 10%
Other 6 9%
Student > Bachelor 5 7%
Student > Postgraduate 4 6%
Other 16 24%
Unknown 15 22%
Readers by discipline Count As %
Medicine and Dentistry 20 30%
Pharmacology, Toxicology and Pharmaceutical Science 11 16%
Agricultural and Biological Sciences 7 10%
Biochemistry, Genetics and Molecular Biology 4 6%
Chemistry 2 3%
Other 6 9%
Unknown 17 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2013.
All research outputs
#5,446,994
of 25,374,917 outputs
Outputs from Alimentary Pharmacology & Therapeutics
#1,827
of 5,634 outputs
Outputs of similar age
#23,626
of 125,296 outputs
Outputs of similar age from Alimentary Pharmacology & Therapeutics
#7
of 31 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,634 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,296 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.